+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Lung Market by Product Type, Technology, Patient Age Group, Component, Application, End-User - Global Forecast 2025-2030- Product Image
Artificial Lung Market by Product Type, Technology, Patient Age Group, Component, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Artificial Lung Market by Product Type, Technology, Patient Age Group, Component, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013918
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Lung Market grew from USD 7.02 billion in 2023 to USD 7.63 billion in 2024. It is expected to continue growing at a CAGR of 8.76%, reaching USD 12.65 billion by 2030.

The artificial lung market, dedicated to devices that mimic or support lung function, addresses severe respiratory conditions, bridging gaps until transplantation or facilitating recovery. Artificial lungs or extracorporeal membrane oxygenation (ECMO) devices are crucial in scenarios like acute respiratory distress syndrome, pneumonia, or chronic obstructive pulmonary disease, providing temporary life support. The scope spans healthcare settings such as hospitals, clinics, and specialized care centers. Rising incidences of respiratory ailments and technological advancements drive market growth, augmented by the increased demand for advanced healthcare solutions and a growing geriatric population. However, considerable challenges persist, including high device costs, stringent regulatory approvals, and potential biocompatibility issues, which could impede market traction. Innovation opportunities flourish in developing portable and more efficient ECMO devices, advancing biocompatibility materials, and integrating AI to optimize device function and patient data monitoring, thereby enhancing patient outcomes and device reliability. Analyzing key influencing factors reveals an expanding prevalence of respiratory disorders with subsequent demand for artificial support systems, alongside potential opportunities in regions with emerging healthcare infrastructural advancements. Investment in R&D and strategic collaborations foster innovation while navigating substantial barriers such as regulatory compliance and market competition. Additionally, growth could be amplified by leveraging telemedicine to enhance ECMO training programs and developing improved blood oxygenation and carbon dioxide removal technologies. To capitalize on market potential, businesses should focus on strategic partnerships and collaborations with healthcare institutions to foster product acceptance, address biocompatibility through novel materials, and enhance device efficiency and usability in clinical settings. In essence, while the market is burgeoning with both challenges and opportunities, strategic investments in research, continuous technological advancements, and efficient regulatory navigation will be pivotal in driving sustainable market growth and expansion in various global regions, particularly in emerging markets.

Understanding Market Dynamics in the Artificial Lung Market

The Artificial Lung Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
    • Technological advancements in artificial lung design and functionality driving industry growth
    • Growing investment and funding in research and development of artificial lung systems
    • Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
  • Market Restraints
    • Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
    • Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
  • Market Opportunities
    • Development of ai-driven artificial lungs to optimize respiratory support systems
    • Regenerative medicine approaches for creating long-lasting and durable artificial lungs
    • Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
  • Market Challenges
    • Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
    • Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs

Exploring Porter’s Five Forces for the Artificial Lung Market

Porter’s Five Forces framework further strengthens the insights of the Artificial Lung Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Artificial Lung Market

External macro-environmental factors deeply influence the performance of the Artificial Lung Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Artificial Lung Market

The Artificial Lung Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Artificial Lung Market

The Artificial Lung Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Artificial Lung Market

The Artificial Lung Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Lung Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ALung Technologies, Inc., B. Braun Melsungen AG, Baxter International Inc., Breethe, Inc., CardiacAssist, Inc., Cleveland Clinic, Drägerwerk AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hemovent GmbH, Maquet Holding B.V. & Co. KG, McGowan Institute for Regenerative Medicine, Medtronic plc, Novalung GmbH, Organ Care System (OCS), Respiratory Assist, Terumo Corporation, Xenios AG, and Xenios USA, Inc.

Market Segmentation & Coverage

This research report categorizes the Artificial Lung Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product Type
    • Extracorporeal Membrane Oxygenation (ECMO)
    • Intrapulmonary Gas Exchange
    • Paracorporeal Artificial Lungs
  • Technology
    • Oxygenator Technology
    • Pump Technology
    • Sensors and Monitors
  • Patient Age Group
    • Adult
    • Geriatric
    • Neonates
    • Pediatric
  • Component
    • Cannulas
    • Controllers
    • Membrane Oxygenators
    • Pumps
  • Application
    • Acute Respiratory Distress Syndrome (ARDS)
    • Cardiopulmonary Bypass
    • Chronic Obstructive Pulmonary Disease (COPD)
  • End-User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory diseases and lung transplantation driving demand for artificial lungs
5.1.1.2. Technological advancements in artificial lung design and functionality driving industry growth
5.1.1.3. Growing investment and funding in research and development of artificial lung systems
5.1.1.4. Rising geriatric population coupled with higher incidences of chronic lung conditions enhancing market demand
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals and expertise needed for the operation and maintenance of artificial lung devices
5.1.2.2. Concerns regarding biocompatibility and long-term durability of artificial lung materials affecting adoption rates
5.1.3. Opportunities
5.1.3.1. Development of ai-driven artificial lungs to optimize respiratory support systems
5.1.3.2. Regenerative medicine approaches for creating long-lasting and durable artificial lungs
5.1.3.3. Integration of internet of things (iot) with artificial lungs for real-time monitoring and maintenance
5.1.4. Challenges
5.1.4.1. Technological limitations and reliability concerns stalling the widespread acceptance of artificial lungs in healthcare settings
5.1.4.2. Ethical considerations and public perception issues influencing the R&D and deployment of artificial lungs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Artificial Lung Market, by Product Type
6.1. Introduction
6.2. Extracorporeal Membrane Oxygenation (ECMO)
6.3. Intrapulmonary Gas Exchange
6.4. Paracorporeal Artificial Lungs
7. Artificial Lung Market, by Technology
7.1. Introduction
7.2. Oxygenator Technology
7.3. Pump Technology
7.4. Sensors and Monitors
8. Artificial Lung Market, by Patient Age Group
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Neonates
8.5. Pediatric
9. Artificial Lung Market, by Component
9.1. Introduction
9.2. Cannulas
9.3. Controllers
9.4. Membrane Oxygenators
9.5. Pumps
10. Artificial Lung Market, by Application
10.1. Introduction
10.2. Acute Respiratory Distress Syndrome (ARDS)
10.3. Cardiopulmonary Bypass
10.4. Chronic Obstructive Pulmonary Disease (COPD)
11. Artificial Lung Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Americas Artificial Lung Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Artificial Lung Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Artificial Lung Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ARTIFICIAL LUNG MARKET RESEARCH PROCESS
FIGURE 2. ARTIFICIAL LUNG MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ARTIFICIAL LUNG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ARTIFICIAL LUNG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ARTIFICIAL LUNG MARKET DYNAMICS
TABLE 7. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY INTRAPULMONARY GAS EXCHANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PARACORPOREAL ARTIFICIAL LUNGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY OXYGENATOR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMP TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY SENSORS AND MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY NEONATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY MEMBRANE OXYGENATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CARDIOPULMONARY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL LUNG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. CANADA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. CANADA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 56. CANADA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ARTIFICIAL LUNG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. CHINA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. CHINA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. CHINA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. CHINA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. CHINA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. INDIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 93. INDIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. INDIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 106. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. JAPAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 142. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. THAILAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 161. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. DENMARK ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 167. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. EGYPT ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 179. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. ITALY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. ITALY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. ITALY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 197. ITALY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. POLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. POLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. POLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. POLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. POLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. QATAR ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. QATAR ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 227. QATAR ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. QATAR ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 269. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. TURKEY ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM ARTIFICIAL LUNG MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. ARTIFICIAL LUNG MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. ARTIFICIAL LUNG MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Artificial Lung market, which are profiled in this report, include:
  • Abbott Laboratories
  • ALung Technologies, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Breethe, Inc.
  • CardiacAssist, Inc.
  • Cleveland Clinic
  • Drägerwerk AG & Co. KGaA
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Hemovent GmbH
  • Maquet Holding B.V. & Co. KG
  • McGowan Institute for Regenerative Medicine
  • Medtronic plc
  • Novalung GmbH
  • Organ Care System (OCS)
  • Respiratory Assist
  • Terumo Corporation
  • Xenios AG
  • Xenios USA, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 7.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.65 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Artificial Lung Market Report 2024 - Product Image

Artificial Lung Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Artificial Lung - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Artificial Lung - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Spirometers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Spirometers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Ventilators Market Outlook, 2028 - Product Image

Ventilators Market Outlook, 2028

  • Report
  • 180 Pages
  • Global
From

About the Artificial Lung Market

The Artificial Lung is a medical device used to provide oxygen to patients with severe respiratory failure. It is a type of extracorporeal membrane oxygenation (ECMO) device, which is a form of life support that oxygenates the blood outside of the body. Artificial Lungs are used to treat a variety of conditions, including acute respiratory distress syndrome, chronic obstructive pulmonary disease, and cardiogenic shock. The device works by removing carbon dioxide from the blood and replacing it with oxygen, allowing the patient to breathe more easily. The Artificial Lung market is a rapidly growing segment of the medical device industry. It is driven by the increasing prevalence of respiratory diseases, as well as advances in technology that have made the devices more efficient and cost-effective. Artificial Lungs are becoming increasingly popular in hospitals and other healthcare settings, as they provide a safe and effective way to treat patients with severe respiratory failure. Some of the major companies in the Artificial Lung market include Medtronic, Getinge, Maquet, and Sorin Group. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.